BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29673122)

  • 21. Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
    aus dem Siepen F; Buss SJ; Andre F; Seitz S; Giannitsis E; Steen H; Katus HA; Kristen AV
    Clin Res Cardiol; 2015 Aug; 104(8):640-7. PubMed ID: 25855392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
    Farhad H; Staziaki PV; Addison D; Coelho-Filho OR; Shah RV; Mitchell RN; Szilveszter B; Abbasi SA; Kwong RY; Scherrer-Crosbie M; Hoffmann U; Jerosch-Herold M; Neilan TG
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27923796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
    Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors.
    Mawad W; Mertens L; Pagano JJ; Riesenkampff E; Reichert MJE; Mital S; Kantor PF; Greenberg M; Liu P; Nathan PC; Grosse-Wortmann L
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):435-442. PubMed ID: 32535624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerobic Fitness Is Related to Myocardial Fibrosis Post-Anthracycline Therapy.
    Kirkham AA; Paterson DI; Haykowsky MJ; Beaudry RI; Mackey JR; Pituskin E; Grenier JG; Thompson RB
    Med Sci Sports Exerc; 2021 Feb; 53(2):267-274. PubMed ID: 32826630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.
    Tham EB; Haykowsky MJ; Chow K; Spavor M; Kaneko S; Khoo NS; Pagano JJ; Mackie AS; Thompson RB
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):48. PubMed ID: 23758789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.
    Kimball A; Patil S; Koczwara B; Raman KS; Perry R; Grover S; Selvanayagam J
    Int J Cardiol; 2018 Jun; 261():159-161. PubMed ID: 29576422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis.
    Mohamed AA; Elmancy LY; Abulola SM; Al-Qattan SA; Mohamed Ibrahim MI; Maayah ZH
    Cardiovasc Toxicol; 2024 Jun; 24(6):563-575. PubMed ID: 38700665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
    Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
    Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
    Shin JM; Choi EY; Park CH; Han K; Kim TH
    Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping.
    Haslbauer JD; Lindner S; Valbuena-Lopez S; Zainal H; Zhou H; D'Angelo T; Pathan F; Arendt CA; Bug G; Serve H; Vogl TJ; Zeiher AM; Carr-White G; Nagel E; Puntmann VO
    Int J Cardiol; 2019 Jan; 275():179-186. PubMed ID: 30360992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
    Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR
    Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
    J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial T1 mapping and extracellular volume quantification in patients with left ventricular non-compaction cardiomyopathy.
    Araujo-Filho JAB; Assuncao AN; Tavares de Melo MD; Bière L; Lima CR; Dantas RN; Nomura CH; Salemi VMC; Jerosch-Herold M; Parga JR
    Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):888-895. PubMed ID: 29518212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot.
    Yim D; Riesenkampff E; Caro-Dominguez P; Yoo SJ; Seed M; Grosse-Wortmann L
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.
    Heck SL; Gulati G; Hoffmann P; von Knobelsdorff-Brenkenhoff F; Storås TH; Ree AH; Gravdehaug B; Røsjø H; Steine K; Geisler J; Schulz-Menger J; Omland T
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):544-552. PubMed ID: 29106497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.